 Connection
Search Results to
This is a "connection" page, showing the details of why an item matched the keywords from your search.
One or more keywords matched the following properties of
BNT162b2 Protection against the Omicron Variant in Children and Adolescents.
| Property | Value |
|
has minor subject area list
|
Adolescent; Case-Control Studies; Child; Child, Preschool; COVID-19 Vaccines; Critical Illness; Hospitalization; Humans; mRNA Vaccines; Vaccine Efficacy; Vaccines, Synthetic
|
|
information resource reference
|
Price AM, Olson SM, Newhams MM, Halasa NB, Boom JA, Sahni LC, Pannaraj PS, Irby K, Bline KE, Maddux AB, Nofziger RA, Cameron MA, Walker TC, Schwartz SP, Mack EH, Smallcomb L, Schuster JE, Hobbs CV, Kamidani S, Tarquinio KM, Bradford TT, Levy ER, Chiotos K, Bhumbra SS, Cvijanovich NZ, Heidemann SM, Cullimore ML, Gertz SJ, Coates BM, Staat MA, Zinter MS, Kong M, Chatani BM, Hume JR, Typpo KV, Maamari M, Flori HR, Tenforde MW, Zambrano LD, Campbell AP, Patel MM, Randolph AG. BNT162b2 Protection against the Omicron Variant in Children and Adolescents. N Engl J Med. 2022 05 19; 386(20):1899-1909.
|
|
label
|
BNT162b2 Protection against the Omicron Variant in Children and Adolescents.
|
|
|